The body has amazing healing power, so our ultimate goal is get your body prepared for long term success
Current estimates suggest: Approximately 900,000 people living with dementia in the UK (Alzheimer's Society) Two-thirds of these have Alzheimer's disease (approximately 600,000 people) Projected to rise to 1.6 million by 2040 as the population ages Healthcare and social care costs exceed 26 billion annually Informal caregiving burden is enormous, affecting family members' employment and wellbeing This disease burden explains why the NHS and research community continue pursuing disease-modifying treatments, despite repeated setbacks like the LIFT-AD trial failure
With Rybelsus , the semaglutide pill, people tend to lose less, about 4% of their body weight
1 GSH titrations and MD results
For cognitive benefits: Acetyl-L-Carnitine is best taken in the morning
The TRIUMPH-4 Phase 3 trial confirmed this: at 68 weeks, mean weight loss had reached 28.7% at 12 mg, an additional 4.5 percentage points beyond the 48-week Phase 2 result